Capital Investment Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $444K | Sell |
997
-35
| -3% | -$15.6K | 0.01% | 473 |
|
|
2025
Q1 | $500K | Buy |
1,032
+190
| +23% | +$92.1K | 0.01% | 436 |
|
|
2024
Q4 | $339K | Sell |
842
-30
| -3% | -$12.1K | 0.01% | 494 |
|
|
2024
Q3 | $405K | Buy |
872
+37
| +4% | +$17.2K | 0.01% | 451 |
|
|
2024
Q2 | $391K | Buy |
835
+80
| +11% | +$37.5K | 0.01% | 442 |
|
|
2024
Q1 | $316K | Sell |
755
-81
| -10% | -$33.9K | 0.01% | 475 |
|
|
2023
Q4 | $340K | Sell |
836
-5
| -0.6% | -$2.04K | 0.01% | 445 |
|
|
2023
Q3 | $293K | Buy |
+841
| New | +$293K | 0.01% | 454 |
|
|
2022
Q3 | – | Sell |
-726
| Closed | -$205K | – | 574 |
|
|
2022
Q2 | $205K | Buy |
+726
| New | +$205K | 0.01% | 516 |
|
|
2022
Q1 | – | Sell |
-926
| Closed | -$203K | – | 619 |
|
|
2021
Q4 | $203K | Buy |
+926
| New | +$203K | 0.01% | 564 |
|